You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR RESCRIPTOR

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for RESCRIPTOR

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00002210 ↗	A Study of Delavirdine Mesylate in Combination With Other Anti-HIV Drugs in HIV-Infected Children and Babies	Completed	Pharmacia and Upjohn	Phase 2	1969-12-31	The purpose of this study is to see if it is safe and effective to give delavirdine mesylate (Rescriptor) plus two nucleoside reverse transcriptase inhibitors (NRTIs) to HIV-infected children and babies. This study also examines how the body processes Rescriptor when taken with 2 NRTIs.
NCT00002211 ↗	Safety and Effectiveness of Giving Combinations of Three or Four Anti-HIV Drugs to HIV-Infected Patients	Completed	Pharmacia and Upjohn	N/A	1969-12-31	The purpose of this study is to see if it is safe and effective to give combinations of three or four anti-HIV drugs to HIV-infected patients. The drugs used in this study are delavirdine (DLV), nelfinavir (NLF), didanosine (ddI), and stavudine (d4T).
NCT00002400 ↗	A Study of Two Anti-HIV Drug Combinations in HIV-Infected Patients	Completed	Pharmacia and Upjohn	N/A	1969-12-31	The purpose of this study is to compare the safety and effectiveness of giving HIV-infected patients delavirdine (DLV) plus zidovudine (ZDV) plus 2 doses of indinavir (IDV) or ZDV plus IDV plus lamivudine (3TC). This study also examines how the body processes DLV when it is given in combination with other drugs.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for RESCRIPTOR

Condition Name

Chart
Table

Condition Name for RESCRIPTOR
Intervention	Trials
HIV Infections	6
HIV-1 Infection	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for RESCRIPTOR
Intervention	Trials
HIV Infections	7
Acquired Immunodeficiency Syndrome	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for RESCRIPTOR

Trials by Country

Map
Table

Trials by Country for RESCRIPTOR
Location	Trials
United States	9
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for RESCRIPTOR
Location	Trials
New Jersey	4
California	2
New York	1
Missouri	1
Maryland	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for RESCRIPTOR

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for RESCRIPTOR
Clinical Trial Phase	Trials
Phase 2/Phase 3	1
Phase 2	2
N/A	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for RESCRIPTOR
Clinical Trial Phase	Trials
Completed	6
Terminated	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for RESCRIPTOR

Sponsor Name

Chart
Table

Sponsor Name for RESCRIPTOR
Sponsor	Trials
Pharmacia and Upjohn	5
Triangle Pharmaceuticals	1
Bristol-Myers Squibb	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for RESCRIPTOR
Sponsor	Trials
Industry	8
NIH	2
Other	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.